Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Stealth BioTherapeutics nets $79.1mm via IPO

Executive Summary

Stealth BioTherapeutics Corp. (developing therapies for diseases involving mitochondrial dysfunction) netted $79.1mm through the initial public offering of 7.09mm American Depositary Shares (including partial exercise of the overallotment; each ADS represents 12 ordinary shares) at $12 each.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies